- Home
- VNO vs BIO Comparison
VNO vs BIO Comparison
Compare VNO & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNO
- BIO
- Stock Information
- Founded
- VNO 1946
- BIO 1952
- Country
- VNO United States
- BIO United States
- Employees
- VNO N/A
- BIO N/A
- Industry
- VNO Real Estate Investment Trusts
- BIO Biotechnology: Laboratory Analytical Instruments
- Sector
- VNO Real Estate
- BIO Industrials
- Exchange
- VNO Nasdaq
- BIO Nasdaq
- Market Cap
- VNO 7.3B
- BIO 8.6B
- IPO Year
- VNO N/A
- BIO N/A
- Fundamental
- Price
- VNO $35.57
- BIO $327.64
- Analyst Decision
- VNO Hold
- BIO Strong Buy
- Analyst Count
- VNO 11
- BIO 4
- Target Price
- VNO $38.55
- BIO $358.50
- AVG Volume (30 Days)
- VNO 1.4M
- BIO 251.8K
- Earning Date
- VNO 11-03-2025
- BIO 10-29-2025
- Dividend Yield
- VNO 2.04%
- BIO N/A
- EPS Growth
- VNO N/A
- BIO N/A
- EPS
- VNO 4.20
- BIO N/A
- Revenue
- VNO $1,903,939,000.00
- BIO $2,557,500,000.00
- Revenue This Year
- VNO N/A
- BIO $1.89
- Revenue Next Year
- VNO $2.94
- BIO $2.45
- P/E Ratio
- VNO $8.62
- BIO N/A
- Revenue Growth
- VNO 1.75
- BIO N/A
- 52 Week Low
- VNO $29.68
- BIO $211.43
- 52 Week High
- VNO $46.52
- BIO $373.69
- Technical
- Relative Strength Index (RSI)
- VNO 35.48
- BIO 60.06
- Support Level
- VNO $33.81
- BIO $302.30
- Resistance Level
- VNO $37.29
- BIO $343.12
- Average True Range (ATR)
- VNO 1.34
- BIO 12.59
- MACD
- VNO -0.18
- BIO -1.37
- Stochastic Oscillator
- VNO 27.89
- BIO 66.86
About VNO Vornado Realty Trust
Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.